Next October 14th, 2021 @ 12pm ET FDA will host the webcast ‘Laboratory and Clinical Studies to Investigate Whether Ranitidine Converts to a Probable Carcinogen in Humans’
Researchers at the Center for Drug Evaluation and Research (CDER) conducted and published clinical and nonclinical studies in response to concerns whether ranitidine converts to the probable human carcinogen N-nitrosodimethylamine (NDMA) in humans. This research found no evidence of elevated NDMA content in urine or blood when participants consumed ranitidine and showed that ranitidine does not convert to NDMA in vitro studies under physiologic gastric nitrite concentrations.
Webcast Registration: *All participants MUST register for webcast to view FDA Grand Rounds!
Webcast Registration Link
Stay Tune for discussion here in Nitrosamine Exchange after the event.